tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
ENTA
Enanta Pharmaceuticals
RESEARCH TOOLSreports
Want to see ENTA full AI Analyst Report?

Enanta Pharmaceuticals (ENTA) Revenue

190 Followers
StatisticsMarket CapRevenue

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had a revenue of 17.16M in the quarter ending Mar 31, 2026, with -7.82%. This bring the company's revenue in the last twelve months to 69.21M, Decreased 3.33%. In the fiscal year ending Sep 30, 2025, Enanta Pharmaceuticals had annual revenue of 65.32M with -3.42% growth.
Revenue (ttm)
69.21M
Revenue Growth
7.37%
P/S Ratio
5.99
Revenue/Employee
$498,656
Employees
131
Market Cap
$391.10M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2025
65.32M-2.31M-3.42%
Sep 30, 2024
67.64M-11.57M-14.61%
Sep 30, 2023
79.20M-6.96M-8.07%
Sep 30, 2022
86.16M-10.91M-11.24%
Sep 30, 2021
97.07M-25.40M-20.74%
Sep 30, 2020
122.47M-82.72M-40.31%
Sep 30, 2019
205.20M-1.43M-0.69%
Sep 30, 2018
206.63M103.81M+100.97%
Sep 30, 2017
102.81M――